-
Je něco špatně v tomto záznamu ?
Heterogeneity of DNA ploidy in endometrial carcinoma: comparison of different tissue samples obtained during diagnosis and treatment
Libalova P., Vernerova Z., Hubickova-Heringova L., Pinterova D., Kolostova K., Bobek V., Tikovsky K., Housa D., Kubecova M., Pecen L., Svoboda B.
Jazyk angličtina Země Řecko
Typ dokumentu srovnávací studie, časopisecké články, Research Support, U.S. Gov't, Non-P.H.S.
Grantová podpora
NS9975
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Free Medical Journals
od 2004 do Před 2 roky
Open Access Digital Library
od 2004-01-01
PubMed
22523302
Knihovny.cz E-zdroje
- MeSH
- aneuploidie MeSH
- biopsie MeSH
- diploidie MeSH
- DNA genetika MeSH
- dospělí MeSH
- endometrium patologie MeSH
- hysterektomie MeSH
- invazivní růst nádoru MeSH
- karcinom genetika patologie chirurgie MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory endometria genetika patologie chirurgie MeSH
- odběr biologického vzorku MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Research Support, U.S. Gov't, Non-P.H.S. MeSH
- srovnávací studie MeSH
AIM: Comparison of DNA ploidy status of different tumour tissue samples (fresh/frozen vs. paraffin-embedded; curettage vs. hysterectomy samples) obtained during diagnosis and treatment of patients with endometrial carcinoma. PATIENTS AND METHODS: DNA ploidy status and conventional prognostic parameters were recorded for 74 patients with endometrial carcinoma prospectively. RESULTS: In 59 (79.7%) patients the DNA status was described as diploid in all analyzed tissue samples. The remaining 15 (20.3%) cases were described as DNA aneuploid in at least one of the corresponding tissue samples. The concordance between DNA ploidy status in fresh vs. paraffin-embedded hysterectomy samples as well as curettage vs. hysterectomy paraffin-embedded samples was high (kappa coefficient κ=0.6348, 95% confidence interval CI=0.3673-0.9023, and p=0.6408, 95% CI=0.3977-0.8838), however, the methods are not interchangeable. CONCLUSION: The DNA ploidy discordance observed in our study group seems to document intratumoral heterogeneity that should be expected when applying DNA ploidy status in the clinical management of endometrial carcinoma.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12034562
- 003
- CZ-PrNML
- 005
- 20160828064316.0
- 007
- ta
- 008
- 121023s2012 gr f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)22523302
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Líbalová, Pavla $7 xx0135162 $u Department of Gynaecology and Obstetrics, Third Faculty of Medicine of Charles University and The Kralovske Vinohrady University Hospital, Prague, Czech Republic. pavla.libalova@lf3.cuni.cz
- 245 10
- $a Heterogeneity of DNA ploidy in endometrial carcinoma: comparison of different tissue samples obtained during diagnosis and treatment / $c Libalova P., Vernerova Z., Hubickova-Heringova L., Pinterova D., Kolostova K., Bobek V., Tikovsky K., Housa D., Kubecova M., Pecen L., Svoboda B.
- 520 3_
- $a AIM: Comparison of DNA ploidy status of different tumour tissue samples (fresh/frozen vs. paraffin-embedded; curettage vs. hysterectomy samples) obtained during diagnosis and treatment of patients with endometrial carcinoma. PATIENTS AND METHODS: DNA ploidy status and conventional prognostic parameters were recorded for 74 patients with endometrial carcinoma prospectively. RESULTS: In 59 (79.7%) patients the DNA status was described as diploid in all analyzed tissue samples. The remaining 15 (20.3%) cases were described as DNA aneuploid in at least one of the corresponding tissue samples. The concordance between DNA ploidy status in fresh vs. paraffin-embedded hysterectomy samples as well as curettage vs. hysterectomy paraffin-embedded samples was high (kappa coefficient κ=0.6348, 95% confidence interval CI=0.3673-0.9023, and p=0.6408, 95% CI=0.3977-0.8838), however, the methods are not interchangeable. CONCLUSION: The DNA ploidy discordance observed in our study group seems to document intratumoral heterogeneity that should be expected when applying DNA ploidy status in the clinical management of endometrial carcinoma.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a aneuploidie $7 D000782
- 650 _2
- $a biopsie $7 D001706
- 650 _2
- $a karcinom $x genetika $x patologie $x chirurgie $7 D002277
- 650 _2
- $a DNA $x genetika $7 D004247
- 650 _2
- $a diploidie $7 D004171
- 650 _2
- $a nádory endometria $x genetika $x patologie $x chirurgie $7 D016889
- 650 _2
- $a endometrium $x patologie $7 D004717
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hysterektomie $7 D007044
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a invazivní růst nádoru $7 D009361
- 650 _2
- $a odběr biologického vzorku $7 D013048
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
- 700 1_
- $a Vernerová, Zdenka, $d 1960-2020 $7 jo2002104672 $u Department of Pathology, Third Faculty of Medicine of Charles University and The Kralovske Vinohrady University Hospital, Prague, Czech Republic
- 700 1_
- $a Hubičková-Heringová, Lucie $7 xx0074015 $u Department of Histology and Embryology, Third Faculty of Medicine of Charles University and The Kralovske Vinohrady University Hospital, Prague, Czech Republic
- 700 1_
- $a Pintérová, Daniela $7 xx0102048 $u Department of Tumour Biology, Third Faculty of Medicine of Charles University and The Kralovske Vinohrady University Hospital, Prague, Czech Republic
- 700 1_
- $a Kološtová, Katarína $7 xx0207726 $u Department of Tumour Biology, Third Faculty of Medicine of Charles University and The Kralovske Vinohrady University Hospital, Prague, Czech Republic
- 700 1_
- $a Bobek, Vladimír $7 xx0162734 $u Department of Tumour Biology, Third Faculty of Medicine of Charles University and The Kralovske Vinohrady University Hospital, Prague, Czech Republic; Department of Surgery, Third Faculty of Medicine of Charles University and The Kralovske Vinohrady University Hospital, Prague, Czech Republic
- 700 1_
- $a Tikovský, Karel, $d 1966- $7 xx0106954 $u Department of Gynaecology and Obstetrics, Third Faculty of Medicine of Charles University and The Kralovske Vinohrady University Hospital, Prague, Czech Republic
- 700 1_
- $a Housa, Daniel, $d 1975- $7 xx0076895 $u Department of Pathology, Glangwili Hospital, Carmarthen, Dyfed, United Kingdom
- 700 1_
- $a Kubecová, Martina $7 xx0083618 $u Department of Oncology, Third Faculty of Medicine of Charles University and The Kralovske Vinohrady University Hospital, Prague, Czech Republic
- 700 1_
- $a Pecen, Ladislav $7 xx0102807 $u SIRO Clinpharm, Prague, Czech Republic
- 700 1_
- $a Svoboda, Bohuslav, $d 1944- $7 nlk19990073914 $u Department of Gynaecology and Obstetrics, Third Faculty of Medicine of Charles University and The Kralovske Vinohrady University Hospital, Prague, Czech Republic
- 773 0_
- $w MED00175831 $t In vivo (Athens, Greece) $x 1791-7549 $g Roč. 26, č. 3 (2012), s. 473-480
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22523302 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20121023 $b ABA008
- 991 __
- $a 20160828064628 $b ABA008
- 999 __
- $a ok $b bmc $g 956572 $s 792059
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 26 $c 3 $d 473-480 $i 1791-7549 $m In Vivo $n In Vivo $x MED00175831
- GRA __
- $a NS9975 $p MZ0
- LZP __
- $b NLK122 $a Pubmed-20121023